API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
72
PharmaCompass offers a list of Vigabatrin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vigabatrin manufacturer or Vigabatrin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vigabatrin manufacturer or Vigabatrin supplier.
PharmaCompass also assists you with knowing the Vigabatrin API Price utilized in the formulation of products. Vigabatrin API Price is not always fixed or binding as the Vigabatrin Price is obtained through a variety of data sources. The Vigabatrin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vigabatrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vigabatrin, including repackagers and relabelers. The FDA regulates Vigabatrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vigabatrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vigabatrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vigabatrin supplier is an individual or a company that provides Vigabatrin active pharmaceutical ingredient (API) or Vigabatrin finished formulations upon request. The Vigabatrin suppliers may include Vigabatrin API manufacturers, exporters, distributors and traders.
click here to find a list of Vigabatrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vigabatrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Vigabatrin active pharmaceutical ingredient (API) in detail. Different forms of Vigabatrin DMFs exist exist since differing nations have different regulations, such as Vigabatrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vigabatrin DMF submitted to regulatory agencies in the US is known as a USDMF. Vigabatrin USDMF includes data on Vigabatrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vigabatrin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vigabatrin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vigabatrin Drug Master File in Korea (Vigabatrin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vigabatrin. The MFDS reviews the Vigabatrin KDMF as part of the drug registration process and uses the information provided in the Vigabatrin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vigabatrin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vigabatrin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vigabatrin suppliers with KDMF on PharmaCompass.
A Vigabatrin CEP of the European Pharmacopoeia monograph is often referred to as a Vigabatrin Certificate of Suitability (COS). The purpose of a Vigabatrin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vigabatrin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vigabatrin to their clients by showing that a Vigabatrin CEP has been issued for it. The manufacturer submits a Vigabatrin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vigabatrin CEP holder for the record. Additionally, the data presented in the Vigabatrin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vigabatrin DMF.
A Vigabatrin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vigabatrin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vigabatrin suppliers with CEP (COS) on PharmaCompass.
A Vigabatrin written confirmation (Vigabatrin WC) is an official document issued by a regulatory agency to a Vigabatrin manufacturer, verifying that the manufacturing facility of a Vigabatrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vigabatrin APIs or Vigabatrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Vigabatrin WC (written confirmation) as part of the regulatory process.
click here to find a list of Vigabatrin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vigabatrin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vigabatrin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vigabatrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vigabatrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vigabatrin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vigabatrin suppliers with NDC on PharmaCompass.
Vigabatrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vigabatrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vigabatrin GMP manufacturer or Vigabatrin GMP API supplier for your needs.
A Vigabatrin CoA (Certificate of Analysis) is a formal document that attests to Vigabatrin's compliance with Vigabatrin specifications and serves as a tool for batch-level quality control.
Vigabatrin CoA mostly includes findings from lab analyses of a specific batch. For each Vigabatrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vigabatrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Vigabatrin EP), Vigabatrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vigabatrin USP).